But healthcare providers want you to understand both the promise and the reality of these treatmentsbecause successful weight loss isn't just about finding the right medication
10.1016/j.molmet.2022.101641 114
Julia Malkowski, ND, DC, BSc, and clinical education doctor for Doctors Data suggests the GI360 panel that provides individualized biomarker data regarding microbiome dysbiosis, diversity, phyla abundance, key bacteria, and metabolites, such as short chain fatty acids (SCFAs)
Using genome-scale models to predict biological capabilities
While our study was observational and does not definitively confirm an association between GLP-1 medications and reduced breast cancer incidence, it does add to the growing body of evidence suggesting that its worth investigating these weight-loss drugs as potential cancer prevention tools, McDonald said
After that initial adjustment period, the digestive system begins to recalibrate, and symptoms gradually decrease